Skip to main content

NASDAQ: NKTR Shareholder Notice: Investigation over Possible Securities Laws Violations by Nektar Therapeutics

San Diego, CA -- (SBWIRE) -- 10/18/2018 -- Nektar Therapeutics is under investigation concerning possible violations of securities laws violations in connection with certain financial statements.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.